Company intelligence / Profile preview
HebeCell
Natick, Massachusetts, United Stateshebecellcorp.com ↗
- Ownership
- Private
- Employees
- ~11
- Development stage
- Other
01
Overview
HebeCell has developed a patented platform to generate allogeneic natural killer (NK) cells from human pluripotent stem cells using bioreactors. Their lead technology enables scalable production of potent off-the-shelf NK cell therapies for oncology and potentially other indications. Early results show promise in preclinical models and initial clinical studies are being prepared or initiated. The company claims their approach yields more potent and less exhausted NK cells compared to traditional expansion methods. Pipeline includes several preclinical programs targeting solid tumors and blood cancers.
- Therapeutic areas
- Infectious DiseasesOncologyOther
- Modalities
- NK cell therapyInduced pluripotent stem cell derived therapyCell therapy
- Industry
- Biotech
02
Drug pipeline
13 assets12 more assets in the full pipeline.
Request access →03
Partnerships
Jacobio PharmaceuticalsAceso Biotech Venture Fund
Beyond the preview
Go deeper on HebeCell.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on HebeCell.